|Last Update: 06/19/13 - 4:00 PM EDT|
|YTD Performance: 3.01%|
|Previous Close: $63.99|
|52 Week Range: $50.88 - $69.03|
|Oustanding Shares: 87,844,521|
|Market Cap: 5,560,558,179|
|Qtr (06/13)||Qtr (09/13)||FY (12/13)||FY (12/14)|
|Number of Analysts||12||11||15||13|
|Growth Rate (Year over Year)||-18.88%||22.89%||-2.10%||16.15%|
ALB earnings estimates through 2014 were reduced based on cautious margin assumptions and slower sales growth, said Jefferies. Price target is $78.
ALB was downgraded to Neutral from Buy, Citigroup said. $71 price target. Weaker bromine trends.
ALB was downgraded from Buy to Hold, Deutsche Bank said. $70 price target. Company lacks near-term catalysts.
ALB was downgraded from Overweight to Neutral, JP Morgan said. Valuation call, based on a $67 price target.
ALB was initiated with an Outperform rating, Robert Baird said. $72 price target. Company has a solid balance sheet and is expanding production capacity.
Shares of ALB now seen reaching $77, Jefferies said. Improvements in end markets. Buy rating.
ALB was upgraded to Buy, Goldman Sachs said. Valuation call, as the stock is already pricing in lower near-term growth.
These stocks are all based in some of the reddest states in the country.
ALB was initiated with an Equal-weight rating, Morgan Stanley said. More upside potential in other chemical "Big Ideas."
Shares of ALB now seen reaching $74, Jefferies said. Estimates also lowered on electronics caution. Buy rating.